Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.46 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | ADK | P55263 | 1/20 | 0.39 |
| ▸ | LPO | P22079 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12075550 | 0.79 | KDM4E (0.40) | BRD4NISCHALDH1A1MTORADK | |
| SCHEMBL308400 | 0.75 | LPO (0.55) | BRD4ALDH1A1LPOKDM4ECASP1 | |
| SCHEMBL11120819 | 0.73 | KDM4E (0.40) | BRD4LPOKDM4ECASP1CASP7 | |
| SCHEMBL31153305 | 0.73 | LPO (0.52) | BRD4ALDH1A1LPOKDM4ECASP1 | |
| Hydrochloric Acid SCHEMBL1806963 | 0.73 | LPO (0.52) | BRD4ALDH1A1LPOKDM4ECASP1 | |
| SCHEMBL17517258 | 0.73 | KDM4E (0.43) | BRD4ALDH1A1KDM4ECASP1CASP7 | |
| SCHEMBL5476182 | 0.72 | LMNA (0.41) | BRD4NISCHALDH1A1SMN1; SMN2MTOR | |
| SCHEMBL11011484 | 0.71 | NISCH (0.38) | BRD4NISCHALDH1A1SMN1; SMN2MTOR | |
| SCHEMBL6017638 | 0.71 | NISCH (0.38) | BRD4NISCHALDH1A1MTORADK | |
| SCHEMBL11503499 | 0.71 | ALDH1A1 (0.61) | BRD4NISCHALDH1A1SMN1; SMN2MTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0086102-B1 | POYOL/IMIDAZOLE CURING AGENTS FOR EPOXY RESINS | INTEREZ, Inc.(a Delaware corporation) (US) | 1986-06-04 | — | — | EP | claimed |
| US-12157785-B2 | Poly(allyl glycidyl ether)-based redox polymer and electrochemical biosensor using same | I-SENS, INC. (KR) | 2024-12-03 | — | — | US | disclosed |
| EP-3854827-B1 | OXIDATION-REDUCTION POLYMER INCLUDING TRANSITION METAL COMPLEX, AND ELECTROCHEMICAL BIOSENSOR USING SAME | I SENS INC (KR) | 2023-11-08 | — | — | EP | disclosed |
| EP-3854827-B1 | OXIDATION-REDUCTION POLYMER INCLUDING TRANSITION METAL COMPLEX, AND ELECTROCHEMICAL BIOSENSOR USING SAME | I SENS INC (KR) | 2023-11-08 | — | — | EP | disclosed |
| EP-4010398-A1 | ADHESIVE COMPOSITIONS | PPG Industries Ohio Inc. (US) | 2022-06-15 | — | — | EP | disclosed |
| US-20220025114-A1 | POLY(ALLYL GLYCIDYL ETHER)-BASED REDOX POLYMER AND ELECTROCHEMICAL BIOSENSOR USING SAME | I-SENS, INC. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-20220025114-A1 | POLY(ALLYL GLYCIDYL ETHER)-BASED REDOX POLYMER AND ELECTROCHEMICAL BIOSENSOR USING SAME | I-SENS, INC. (KR) | 2022-01-27 | — | — | US | disclosed |
| US-20210347926-A1 | OXIDATION-REDUCTION POLYMER INCLUDING TRANSITION METAL COMPLEX, AND ELECTROCHEMICAL BIOSENSOR USING SAME | I-SENS, INC. (KR) | 2021-11-11 | — | — | US | disclosed |
| US-20210347926-A1 | OXIDATION-REDUCTION POLYMER INCLUDING TRANSITION METAL COMPLEX, AND ELECTROCHEMICAL BIOSENSOR USING SAME | I-SENS, INC. (KR) | 2021-11-11 | — | — | US | disclosed |
| EP-3854833-A1 | POLY(ALLYL GLYCIDYL ETHER)-BASED REDOX POLYMER AND ELECTROCHEMICAL BIOSENSOR USING SAME | i-Sens, Inc. (KR) | 2021-07-28 | — | — | EP | disclosed |
| US-20080248354-A1 | Enzyme Electrode, and Device, Sensor, Fuel Cell and Electrochemical Reactor Employing the Enzyme Electrode | CANON KABUSHIKI KAISHA (JP) | 2008-10-09 | — | — | US | disclosed |
| EP-1807407-A1 | AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-07-18 | — | — | EP | disclosed |
| US-20070056852-A1 | Enzyme electrode sensor fuel cell and electrochemical reactor | CANON KABUSHIKI KAISHA (JP) | 2007-03-15 | — | — | US | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
| US-20060100201-A1 | Inhibitors of c-fms kinase | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-05-11 | — | — | US | disclosed |
| WO-2006047504-A1 | AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006009324-A1 | ENZYME ELECTRODE, AND DEVICE, SENSOR, FUEL CELL AND ELECTROCHEMICAL REACTOR EMPLOYING THE ENZYME ELECTRODE | CANON KABUSHIKI KAISHA (JP) | 2006-01-26 | — | — | WO | disclosed |
| WO-2006009328-A1 | ENZYME ELECTRODE, SENSOR, FUEL CELL, AND ELECTROCHEMICAL REACTOR | CANON KABUSHIKI KAISHA (JP) | 2006-01-26 | — | — | WO | disclosed |
| US-4053444-A | COLLOIDAL POLYAMIC ACID ELECTRODEPOSITION COMPOSITIONS AND PROCESS FOR PREPARING SAID COMPOSITIONS | WESTINGHOUSE ELECTRIC CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100201-A1 | Inhibitors of c-fms kinase | MUSK, FLT3, FES | BRD4 3471/4885NISCH 4206/4885ALDH1A1 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.